Generic Formulation

Phenobarbitone sodium

Indication

Seizures and epilepsy; long-term anticonvulsant control.

Contraindications

Severe hepatic impairment. A controlled drug in most jurisdictions.

Side Effects

Sedation, ataxia, polyphagia, polydipsia and polyuria early in treatment; hepatotoxicity on long-term use.

Pregnancy & Lactation

Crosses the placenta; use only where seizure control outweighs the risk.

Dose Guidance

DogPO

Dose

2 – 3

mg/kg

Frequency

q12h

Duration

long term days

Steady state takes 2-3 weeks; do not escalate before then. Monitor liver function on long-term use. Verify against the product label before use.

CatPO

Dose

2 – 3

mg/kg

Frequency

q12h

Duration

long term days

Steady state takes 2-3 weeks; do not escalate before then. Monitor liver function on long-term use. Verify against the product label before use.

Available Brands

3 Products